CollPlant Biotechnologies Ltd (CLGN) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
No case yet. It builds on the next filing, report or 13F period.
CollPlant Biotechnologies Ltd
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies
High 4.68 at 1:45 pm ET, low 3.91 at 8:00 am ET.
CollPlant Biotechnologies Ltd has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
14 managers report a position worth $583,355 between them, and 2 of them hold 80% of it.
CLGN (CollPlant Biotechnologies Ltd) has 1 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.